Patent · US Active

Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors

US9199973B2 · kind B2 · utility

14Cited by
19References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 10, 2014
Grant dateDec 1, 2015
Priority date—
Expiry dateNov 10, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A pharmaceutical formulation comprising the compound of formula

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.